This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: exercise

February 2011 Br J Cardiol 2011;18:s13-s5

Foreword

Julian Halcox - Professor of Cardiology and Consultant Cardiologist

Abstract

To address the question of increasing engagement with CR programmes in target areas, in 2009, I chaired a Steering Committee convened by Abbott Healthcare Products Ltd. (formerly Solvay Healthcare) called ‘Setting the Standard for Cardiac Rehabilitation’ (START). The Steering Committee advised that the existing Cardiac Networks in each region would be the best forum for disseminating information about changes in CR funding and standards of care in this field. Abbott Healthcare Products Ltd. kindly agreed to organise a series of meetings in the UK, held during 2009 and early 2010, with the aim of raising awareness of the importance of CR a

| Full text

February 2011 Br J Cardiol 2011;18:s13-s5

Why is cardiac rehabilitation so important?

John Buckley

Abstract

WHO definition The World Health Organization (WHO) defined CR in 1993 in a timeless way that is inclusive and sensitive to the psychosocial, biomedical, professional expertise and service delivery mode and location elements required of a contemporary CR service. “The sum of activities required to influence favourably the underlying cause of the disease so that (people) may by their own efforts preserve, or resume when lost, as normal a place in the community… …it must be integrated within secondary prevention services of which it forms one facet”.3 BACR definition This article reflects on how this definition dovetails with the BACR St

| Full text

February 2011 Br J Cardiol 2011;18:s13-s5

Overview of UK cardiac rehabilitation services: a West Midlands perspective 

Dr E Jane Flint

Abstract

In fact, fewer than half of networks have ever benefited from Patient Choice Revascularisation Pathway monies, which were originally intended to support CR also.2 The START meeting in Birmingham in December 2009 was an opportunity to celebrate the innovative approach undertaken by the West Midlands’ Regional NSF Implementation Group for Cardiac Rehabilitation and Secondary Prevention, describing local CR pathway service standards against which West Midlands’ CR programmes could be audited to inform commissioning. The subsequent proportional allocation of ‘Patient Choice’ rehabilitation funding across Birmingham and the Black Country w

| Full text

February 2011 Br J Cardiol 2011;18:s8-s10

Sharing best practices: a nurse-led cardiac prevention and rehabilitation service

Judith Edwards 

Abstract

The service at Charing Cross was used as the model for EUROACTION, a randomised, controlled trial of a preventive cardiology programme, conducted in eight European countries, including the UK. This nurse-led multidisciplinary programme significantly improved the management of lifestyle and medical risk factors for cardiovascular disease prevention in coronary patients and patients at high multifactorial risk for developing heart disease.1 The principles of the EUROACTION programme were used to found The MyAction community programme, commissioned in 2008 by NHS Westminster as a model for preventive cardiology care for its residents. The Imperi

| Full text

February 2011 Br J Cardiol 2011;18:s11-s2

Exercise: tipping the balance towards sustained participation and lasting benefits

John Buckley

Abstract

What is beneficial exercise? A prime question needs to be considered before furthering this discussion: what is meant by beneficial exercise? The benefits of exercise impact on all aspects of health – physiological, psychological and social. A study by Fox (1999) found that short bouts of any activity, even low-intensity activity that may not bring about a significant physiological risk factor change, if it is performed regularly, will provide psychological benefits to self-esteem and self-efficacy, and reductions in anxiety and depression.2 Angina patients engaging in regular walking on a similar premise to that expressed by Fox show signi

| Full text

February 2011 Br J Cardiol 2011;18:s13-s5

START: insights from the regions

Amarjit Sethi, John Townend, Adrian Brady, Julian Halcox

Abstract

North West London To try and identify local barriers and share good practice, we have been regularly reviewing our cardiac rehabilitation (CR) services in North West London. Through this process we hope to increase the average uptake in a step-wise fashion from 50–60% to the national target of 85%.1 Lack of appropriately funded services and low staffing levels are real problems across the sector, unfortunately. Nevertheless, some innovative approaches to CR are taking place. The uptake of CR services after primary percutaneous coronary intervention (PPCI) for myocardial infarction has increased from 26% to 84% at Imperial College Healthcare

| Full text
News from the American Heart Association Scientific Sessions 2009

February 2010 Br J Cardiol 2010;17:13-18

News from the American Heart Association Scientific Sessions 2009

BJCardio editorial staff

Abstract

ARBITER 6: niacin superior to ezetimibe for slowing atherosclerosis Use of extended-release niacin resulted in a significant benefit on atherosclerosis compared with ezetimibe in patients already taking statins in the ARBITER 6-HALTS trial. The trial, presented at the meeting by Dr Allen Taylor (Medstar Research Institute, Washington DC, US), compared two distinct lipid-modifying strategies in patients with known vascular disease already on statins who had LDL-cholesterol levels <100 mg/dL (2.56 mmol/L) and moderately low HDL-cholesterol levels (<50 mg/dL [1.28 mmol/L]). Among the 363 patients enrolled in the study, half were randomised

| Full text

November 2008 Br J Cardiol 2008;15:284–8

News from the Scientific Sessions 2008 of the American Heart Association

BJCardio editorial team

Abstract

JUPITER shows large cardiovascular risk reduction in primary prevention The eagerly awaited landmark JUPITER trial shows that the treatment of apparently healthy patients – who had low levels of low-density lipoprotein (LDL) cholesterol but elevated C-reactive-protein (CRP) levels – with rosuvastatin cuts their risk of cardiovascular disease morbidity and mortality by around 50%. The results were the first late-breaking trial data reported here at the AHA 2008 Scientific Sessions and were also published in the New England Journal of Medicine (N Engl J Med 2008; 359: 2195-207). JUPITER was designed as a four-year study but was stopped in

| Full text

May 2007 Br J Cardiol 2007;14:175-78

Clinical trials versus the real world: the example of cardiac rehabilitation

Rod S Taylor, Hugh JN Bethell, David A Brodie

Abstract

No content available

| Full text

September 2006 Br J Cardiol 2006;13:332-37

Lifestyle management of blood pressure

BJCardio editorial team

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now